Literature DB >> 28591789

Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection.

Benjamin D Sirbu1,2, Melinda M Soriano3, Carl Manzo1, Jessica Lum1, Dale N Gerding1,2, Stuart Johnson1,2.   

Abstract

We retrospectively studied vancomycin taper and pulse treatment on 100 consecutive, evaluable patients with recurrent Clostridium difficile infection. Following taper to once-daily vancomycin dosing, 22 of 36 patients (61%) who received every-other-day dosing (QOD) and 50 of 64 (81%) who received QOD followed by every-third-day dosing were cured (P = .03). Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  C. difficile; pulse; recurrence; taper; vancomycin

Mesh：

Substances：

Year:  2017        PMID： 28591789     DOI： 10.1093/cid/cix529

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

Review 1.  Extended duration vancomycin in recurrent Clostridium difficile infection: a systematic review.

Authors:  Madison M Murphy; Edna Patatanian; Mark A Gales
Journal:  Ther Adv Infect Dis       Date:  2018-09-12

Review 2.  Recent Issues in Pediatric Clostridium difficile Infection.

Authors:  Jason A Clayton; Philip Toltzis
Journal:  Curr Infect Dis Rep       Date:  2017-11-07       Impact factor: 3.725

Review 3.  Management of adult Clostridium difficile digestive contaminations: a literature review.

Authors:  Fanny Mathias; Christophe Curti; Marc Montana; Charléric Bornet; Patrice Vanelle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-29       Impact factor: 3.267

4.  Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.

Authors:  Myreen E Tomas; Thriveen S C Mana; Brigid M Wilson; Michelle M Nerandzic; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

5.  Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection.

Authors:  Zainab I Abdali; Tracy E Roberts; Pelham Barton; Peter M Hawkey
Journal:  EClinicalMedicine       Date:  2020-06-27

Review 6.  Clostridioides difficile therapeutics: guidelines and beyond.

Authors:  Robert Orenstein; Roberto L Patron
Journal:  Ther Adv Infect Dis       Date:  2019-08-13

7.  Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent Clostridioides difficile infection in the Japanese setting: a case control study.

Authors:  Takumi Umemura; Aiko Ota; Yoshikazu Mutoh; Chihiro Norizuki; Takahito Mizuno; Koji Kozaki; Yoshiaki Ikeda; Toshihiko Ichihara
Journal:  J Pharm Health Care Sci       Date:  2019-08-08

8.  The Challenging Conundrum of Diagnosing and Managing Clostridium difficile Infection.

Authors:  Dale N Gerding; Stuart Johnson
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2017-06-09

9.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.